BioSpace News Archive

Six Online Sessions Help New Interns Adjust to Demands of Residency; Topics Include Time Management, Professionalism, Order Writing, and More

Clinical interventions provided by a nutrition support team can prevent hospital readmission in patients with short bowel syndrome receiving home parenteral nutrition, saving millions in costs annually, suggests a study¹ by Option Care Enterprises, Inc., the nation’s leading provider of home and alternate site infusion therapy services.

ZULRESSO is the first and only treatment specifically indicated for postpartum depression

Ocular Therapeutix, Inc announced that it will host a Research & Development Day to provide updates on the commercial plans for DEXTENZA and a deeper dive into the hydrogel platform and the Company’s pipeline.

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies.

CStone Pharmaceuticals (“CStone"; HKEX: 2616) today announced that China’s National Medical Products Administration (NMPA) has approved the clinical trial application to begin a Phase 1 trial in China for BLU-667 (CS3009), a highly selective and potent RET inhibitor discovered by CStone’s partner Blueprint Medicines.

Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20%

Abzena announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture.

Liht Cannabis Corp. announced that the Company’s current Chief Financial Officer, Hanspaul Pannu, has been appointed as President and Nilda Rivera has been appointed Chief Financial Officer.

Management consulting firm North Highland is pleased to announce that Amy Andersen will join the firm as vice president and will be based in the firm’s San Francisco office.